Moderate

Allergic disease in pregnancy (rhinitis, urticaria, safe medications)

Allergy in pregnancy · Obstetric
Physician-written · Verified by three sets of doctors · Reviewed November 2026

Bedside summary

Management of rhinitis, urticaria/angioedema, atopic dermatitis and allergic reactions in pregnancy, balancing symptom control against fetal medication risk. Anaphylaxis in pregnancy is an emergency — epinephrine is first-line and must NOT be withheld. DRAFT for clinician review.

Red flags

  • Anaphylaxis — treat immediately with epinephrine
  • Laryngopathia gravidarum: progressive dyspnoea/hoarseness that can mimic laryngeal angioedema and occasionally needs an artificial airway
  • Features of intrahepatic cholestasis of pregnancy (palm/sole pruritus, raised bile acids — fetal risk) masquerading as 'eczema'
  • Uncontrolled rhinitis worsening asthma

Assessment

Differential diagnosis

  • Pregnancy rhinitis (congestion ≥6 weeks, resolves within 2 weeks postpartum) vs allergic rhinitis vs rhinitis medicamentosa vs sinusitis
  • Urticaria vs PUPPP/polymorphic eruption of pregnancy, pemphigoid gestationis, intrahepatic cholestasis of pregnancy
  • Atopic eruption of pregnancy
  • Laryngopathia gravidarum vs true laryngeal angioedema

Investigations

  • Clinical
  • In-vitro specific-IgE preferred over skin testing in pregnancy (rare systemic-reaction risk)
  • Liver function / bile acids if unremitting pruritus (exclude cholestasis of pregnancy)

Management

  • Maximise allergen avoidance and nonpharmacologic measures (saline irrigation, nasal dilator strips, head-of-bed elevation 30–45°)
  • Use the lowest effective dose of the best-studied agent
  • Do NOT withhold epinephrine for anaphylaxis
  • Do not initiate immunotherapy in pregnancy (continue if already tolerating)
  • Evaluate significant allergy before pregnancy where possible

Drugs & doses

Anaphylaxis — IM epinephrine is the treatment of choice in pregnancy; do not withhold (maternal hypoxia/hypotension harms mother and fetus).
Rhinitis — saline irrigation first; intranasal cromolyn 1 spray/nostril up to 6×/day for mild disease; intranasal corticosteroid for moderate–severe, using agents OTHER than triamcinolone (triamcinolone carried a respiratory-malformation signal; budesonide often chosen); preferred oral antihistamines are second-generation cetirizine, loratadine or fexofenadine; chlorpheniramine 4 mg every 4–6 h (max 24 mg/day) is the first-generation agent of choice (sedating; useful at night).
Decongestants — avoid oral decongestants in the first trimester and in any hypertensive patient; after the first trimester, pseudoephedrine 60 mg up to 4×/day (or 120 mg extended-release twice daily) for severe congestion; intranasal oxymetazoline only very briefly (≤3 days); avoid phenylephrine and phenylpropanolamine.
Urticaria — second-generation H1 antihistamine (cetirizine, loratadine, fexofenadine) at standard or up-titrated dose; severe flares: oral prednisone (preferred over other oral steroids; avoid first trimester if possible); omalizumab for severe refractory chronic urticaria (reassuring data).
Atopic dermatitis — emollients + low/moderate-potency topical corticosteroid; hydrocortisone 0.5–2.5% twice daily is a good initial choice; use potent/superpotent steroids sparingly (third-trimester potent-steroid use linked to low birth weight); avoid topical tacrolimus/pimecrolimus and JAK inhibitors; prednisone (not first trimester) for flares; superinfection — penicillinase-resistant penicillin, or erythromycin if penicillin-allergic.
Allergen immunotherapy — continue (do not increase the dose; some reduce it) in patients already tolerating and benefiting; do NOT initiate in pregnancy; stop if a systemic reaction occurs.
Avoid — herbal/unregulated remedies; antihistamine nasal sprays (azelastine/olopatadine) lack human pregnancy data; montelukast only if there was clear prior benefit.

Disposition

Most managed outpatient with obstetric coordination. Anaphylaxis — resuscitate, observe for biphasic reaction, involve obstetrics, discharge with epinephrine autoinjector and action plan. Suspected cholestasis or airway compromise — admit with obstetric and specialist input.

Complications & pitfalls

  • Uncontrolled rhinitis worsening sleep and asthma
  • Progression of untreated anaphylaxis harming mother and fetus
  • Rhinitis medicamentosa
  • Misdiagnosis of a pregnancy-specific dermatosis (e.g. cholestasis) as eczema

Exam pearls

  • Never withhold epinephrine in a pregnant anaphylaxis patient
  • Cetirizine/loratadine/fexofenadine and (first-generation) chlorpheniramine are the go-to antihistamines
  • Avoid triamcinolone among the intranasal steroids
  • Oral decongestants are off-limits in the first trimester
  • Immunotherapy is continued but never started in pregnancy

Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.